Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population

Clinical Genetics

Volumn 81, Issue 3, 2012, Pages 278-283

  Borowiec, M ^a   Antosik, K ^a   Fendler, W ^a   Deja, G ^b   Jarosz Chobot, P ^b   Mysliwiec, M ^c   Zmyslowska, A ^a   Malecki, M ^d   Szadkowska, A ^a   Mlynarski, W ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

DNA sequencing; Founder effect; Monogenic diabetes; Neonatal diabetes

Indexed keywords

C PEPTIDE; GLUCOKINASE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERGLYCEMIA; INDEL MUTATION; INFANT; INHERITANCE; INSULIN TREATMENT; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MONOGENIC DIABETES; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEWBORN DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PATIENT SELECTION; PRIORITY JOURNAL; SYMPTOM;

DIABETES MELLITUS; FEMALE; FOUNDER EFFECT; HUMANS; MALE; MUTATION; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84856417007     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01656.x     Document Type: Article

References (19)

1. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
2. Hattersley AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998: 15: 15-24.
3. Polak M, Shield J. Neonatal and very-early-onset diabetes mellitus. Semin Neonatol 2004: 9: 59-65.
4. Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993: 328: 697-702.
5. Iynedjian PB, Mobius G, Seitz HJ, Wollheim CB, Renold AE. Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets. Proc Natl Acad Sci U S A 1986: 83: 1998-2001.
6. Frayling TM, Lindgren CM, Chevre JC et al. A genome-wide scan in families with maturity-onset diabetes of the young: evidence for further genetic heterogeneity. Diabetes 2003: 52: 872-881.
7. Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet 2003: 361: 301-307.
8. Gloyn AL, Pearson ER, Antcliff JF et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004: 350: 1838-1849.
9. Sagen JV, Raeder H, Hathout E et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004: 53: 2713-2718.
10. Malecki MT, Jhala US, Antonellis A et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999: 23: 323-328.
11. Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008: 51: 546-553.
12. Osbak KK, Colclough K, Saint-Martin C et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009: 30: 1512-1526.
13. Cuesta-Muñoz AL, Tuomi T, Cobo-Vuilleumier N et al. Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY). Diabetes Care 2010: 33: 290-292.
14. Borowiec M, Fendler W, Antosik K et al. Optimization of monogenic diabetes screening programme - initial report on recruitment efficacy of the TEAM project. Pediatr Endocrinol Diabetes Metabol 2010: 16: 73-76.
15. Kelliny C, Ekelund U, Andersen LB et al. Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study. Diabetes 2009: 58: 2939-2945.
16. Lorini R, Klersy C, d'Annunzio G et al. Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. Diabetes Care 2009: 32: 1864-1866.
17. Pruhova S, Dusatkova P, Sumnik Z et al. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes 2010: 11: 529-535.
18. Tam CH, Ma RC, So WY et al. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Diabetes 2009: 58: 765-769.
19. Schnyder S, Mullis PE, Ellard S, Hattersley AT, Fluck CE. Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment. Swiss Med Wkly 2005: 135: 352-356.